From The Washington Post:
Approved for sale in 1999, Tequin has faced questions about its effects on blood sugar, being associated with both high- and low-blood sugar in some patients.Technorati Tags: drugs, fda, washington post, tequin
In February, the Food and Drug Administration required increased warnings on the drug's label. The manufacturer has warned that it should not be used by diabetics and said the elderly and those with kidney disease are more likely to have problems.
Miller said that while Bristol-Myers Squibb will stop making and selling the drug, stocks currently available are not being recalled. He urged people using Tequin not to discontinue it until they talk with their physician about an alternative.